Total and ionized serum magnesium and calcium levels during magnesium sulfate administration for preterm labor
- PMID: 29372150
- PMCID: PMC5780321
- DOI: 10.5468/ogs.2018.61.1.56
Total and ionized serum magnesium and calcium levels during magnesium sulfate administration for preterm labor
Abstract
Objective: This study aimed to estimate the association between total and ionized magnesium, and the changes in serum magnesium and calcium levels in patients with preterm labor during magnesium sulfate (MgSO4) administration.
Methods: The study population included 64 women who were candidates for intravenous MgSO4 treatment for preterm labor. Serial blood samples were taken and measured total magnesium (T-Mg), ionized magnesium (I-Mg), total calcium (T-Ca), and ionized calcium (I-Ca) levels every one-week interval (1st, 2nd, 3rd).
Results: There was no significant difference in T-Mg and I-Mg levels during MgSO4 administration (P>0.05). There was no significant difference in T-Ca and I-Ca levels during MgSO4 administration (P>0.05). Compared before and after administration of MgSO4, T-Mg and I-Mg levels and T-Ca levels were changed allow statistically significant (P<0.05). But, there was no significant difference in the I-Ca serum levels before and after MgSO4 administration (P=0.495). The I-Mg levels for patients with adverse effect were higher than other group but did not reach statistical significance (P>0.05). There was significant correlation between levels of I-Mg and T-Mg (I-Mg=0.395×T-Mg+0.144, P<0.01).
Conclusion: There were no significant differences in serum Mg and Ca levels during MgSO4 administration for preterm labor. Compared to the before and after administration of MgSO4, only I-Ca levels were not substantially changed. There are significant correlations between I-Mg and T-Mg levels during administration of MgSO4 and I-Mg level seemed to have more correlation with adverse effect than T-Mg.
Keywords: Calcium; Magnesium; Magnesium sulfate; Obstetric labor, premature.
Conflict of interest statement
Conflict of interest: No potential conflict of interest relevant to this article was reported.
Figures


References
-
- Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol. 1983;147:277–284. - PubMed
-
- Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol. 1990;162:1141–1145. - PubMed
-
- American College of Obstetricians and Gynecologists Committee on Obstetric PracticeSociety for Maternal-Fetal Medicine Committee Opinion No. 455: magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010;115:669–671. - PubMed
-
- ACOG technical bulletin. Preterm labor. Number 206--June 1995 (replaces no. 133, October 1989) Int J Gynaecol Obstet. 1995;50:303–313. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous